Skip to main content
. Author manuscript; available in PMC: 2016 Dec 14.
Published in final edited form as: Nanoscale. 2015 Dec 14;7(46):19438–19447. doi: 10.1039/c5nr04587h

Figure 2.

Figure 2

a) Typical μPET/CT images of subcutaneous BT-474 tumor-bearing mice treated with [64Cu]CuS NPs or 64CuCl2 at 24 h after intratumoral injection. b) Biodistribution of [64Cu]CuS NPs and 64CuCl2 in mice bearing BT474 tumors at 24 h after intratumoral injection. * indicates p<0.001. c) Autoradiographs of BT474 tumors from mice treated with [64Cu]CuS NPs or 64CuCl2 24 h post-injection.